Five consecutive cases in which the AngioVac aspiration cannula was used for the management of pulmonary embolism (PE) were retrospectively reviewed. Four cases (80%) presented with massive PE, and two (40%) were technically successful (reduction in Miller index ≥ 5). Four patients (80%) died at a mean of 7.3 days after the procedure, including one death related to right ventricular free wall perforation. Although the AngioVac aspiration cannula has shown clinical promise in a variety of clinical applications, early experience in the pulmonary arteries has shown limited success, and further study and careful patient selection are required.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvir.2016.01.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transcatheter mass extraction of left-sided cardiac masses has gained popularity in recent years, with scarce data on effectiveness, safety, and types of devices used. Mostly, left-sided aspirations use mechanical and continuous-flow-mediated devices (the AngioVac [AngioDynamics] and Penumbra systems [Penumbra]). To our knowledge, the use of manual aspiration devices has not been reported yet.
View Article and Find Full Text PDFCardioembolic Stroke Due to Prosthetic Valve Endocarditis Caused by : A Case Report.
Case Rep Infect Dis
November 2024
Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Article Synopsis
- - A 50-year-old man with a history of double prosthetic valves and uncontrolled diabetes presented with symptoms of a cerebellar stroke, likely due to embolism from prosthetic valve endocarditis (PVE).
- - Diagnosis was complicated and required transesophageal echocardiography (TEE), revealing vegetations on the mitral valve prosthesis; the patient was started on antifungal therapy but faced financial barriers to surgery.
- - Due to persistent infection, the AngioVac system was considered for vegetative aspiration, but ultimately, the patient was discharged with a long-term plan for suppressive antifungal treatment instead of surgery.
Current trends and challenges in infective endocarditis.
Curr Opin Cardiol
November 2024
Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, Ontario.
Article Synopsis
- Infective endocarditis (IE) is on the rise globally, with a focus on healthcare-associated (HAIE) and drug-use-associated (DUA-IE) infections and difficulties in treating prosthetic valve infections.
- Recent findings show that Staphylococcus aureus is the leading cause of IE, alongside the challenges posed by drug-resistant organisms and advances in diagnostics that help identify hard-to-detect cases.
- Effective treatment relies on prompt diagnosis through advanced imaging, appropriate antibiotics, and coordinated care from multiple specialties, including early surgical intervention for improved patient outcomes.*
Article Synopsis
- Intravascular and intracardiac masses include thrombi, tumors, and vegetations, impacting the heart's chambers and circulation.
- Treatment has traditionally been surgical or involves anticoagulation, but there's a shift towards minimally invasive techniques due to patient complexities.
- The AngioVac System, initially for right-sided heart thrombi, has expanded its use to treat right-sided endocarditis and left-sided masses effectively.
A Retrospective Analysis of AngioVac Outcomes at a Tertiary Care Center.
J Soc Cardiovasc Angiogr Interv
June 2024
Division of Cardiology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia.
Background: The AngioVac system is a vacuum aspiration device approved for removal of right-sided cardiac thrombi. It has also been used for management of right-sided endocarditis in selected cases. Retrospective case series have reported high success rate and acceptable 30-day mortality, but there is limited data regarding outcomes beyond the immediate postoperative period.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!